Post-approval studies (Phase 4)WithdrawnNCT03504566
What this trial is testing
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)
Who this might be right for
Diabetic Nephropathy Type 2
Steno Diabetes Center Copenhagen